English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Pharma & Biotech BioTech (Sci&Research)
US Tests Confirm Path-Away(R) Organically Kills SARS-CoV-2 Virus
Oct 21, 2020 21:00 HKT
Olympus to Support Endoscopic AI Diagnosis Education for Doctors in India and to Launch AI Diagnostic Support Application
Oct 20, 2020 10:00 HKT
TOT BIOPHARM International Company Limited Optimises Company Management Structure to Promote Strategic Development Upgrade
Oct 16, 2020 09:00 HKT
Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin
Oct 14, 2020 14:00 HKT
Broncus Closes Series C Financing
Oct 14, 2020 12:00 HKT
Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System
Oct 09, 2020 15:00 HKT
China Biotech Services (8037.HK) and National Institute for Viral Disease Control and Prevention (NIVDC) to develop Genetically Engineered Recombinant Vaccine for COVID-19
Oct 05, 2020 21:30 HKT
Impact BioMedical to Begin Efficacy Testing Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc.
Oct 05, 2020 15:25 HKT
Holista Signs Agreement with Costanzo's to Launch World's Lowest Glycaemic Index (GI) Clean Label Bread
Oct 01, 2020 15:00 HKT
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary, Announces Exclusive In-license from Singapore-based Accelerate Technologies to Co-Develop Molecular Based Rapid Pathogen Diagnostics to Track Pathogenic Genome
Sep 29, 2020 18:35 HKT
Insumate(R)--Patented Peptide Sequence mcIRBP-19: a Boon for Diabetics Says Greenyn Biotechnology
Sep 28, 2020 16:00 HKT
Agilex Biolabs Develops World's Most Accurate Cannabinoid Assay
Sep 23, 2020 12:00 HKT
Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America
Sep 22, 2020 07:50 HKT
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance
Sep 18, 2020 17:00 HKT
Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
Sep 17, 2020 20:30 HKT
NanoViricides Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19
Sep 16, 2020 18:15 HKT
Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum on September 10
Sep 08, 2020 15:52 HKT
Aptorum Group Joins the BEAM Alliance To Combat Antimicrobial Resistance
Sep 08, 2020 15:46 HKT
Regent Pacific enters longevity medicine business driven by leading AI technology through acquisition of Deep Longevity, Inc.
Sep 02, 2020 21:21 HKT
AI Startup Deep Longevity Launches with Series A Financing and New AI System to Tackle Aging-Related Diseases
Sep 02, 2020 08:55 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: